368 related articles for article (PubMed ID: 25063873)
1. Noncanonical NF-κB activation mediates STAT3-stimulated IDO upregulation in myeloid-derived suppressor cells in breast cancer.
Yu J; Wang Y; Yan F; Zhang P; Li H; Zhao H; Yan C; Yan F; Ren X
J Immunol; 2014 Sep; 193(5):2574-86. PubMed ID: 25063873
[TBL] [Abstract][Full Text] [Related]
2. Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer.
Yu J; Du W; Yan F; Wang Y; Li H; Cao S; Yu W; Shen C; Liu J; Ren X
J Immunol; 2013 Apr; 190(7):3783-97. PubMed ID: 23440412
[TBL] [Abstract][Full Text] [Related]
3. STAT3 Silencing and TLR7/8 Pathway Activation Repolarize and Suppress Myeloid-Derived Suppressor Cells From Breast Cancer Patients.
Safarzadeh E; Mohammadi A; Mansoori B; Duijf PHG; Hashemzadeh S; Khaze V; Kazemi T; Derakhshani A; Silvestris N; Baradaran B
Front Immunol; 2020; 11():613215. PubMed ID: 33679700
[TBL] [Abstract][Full Text] [Related]
4. Tumor-associated GM-CSF overexpression induces immunoinhibitory molecules via STAT3 in myeloid-suppressor cells infiltrating liver metastases.
Thorn M; Guha P; Cunetta M; Espat NJ; Miller G; Junghans RP; Katz SC
Cancer Gene Ther; 2016 Jun; 23(6):188-98. PubMed ID: 27199222
[TBL] [Abstract][Full Text] [Related]
5. Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer.
Li F; Zhao Y; Wei L; Li S; Liu J
Cancer Biol Ther; 2018 Aug; 19(8):695-705. PubMed ID: 29621426
[TBL] [Abstract][Full Text] [Related]
6. CARD9 prevents lung cancer development by suppressing the expansion of myeloid-derived suppressor cells and IDO production.
Qu J; Liu L; Xu Q; Ren J; Xu Z; Dou H; Shen S; Hou Y; Mou Y; Wang T
Int J Cancer; 2019 Oct; 145(8):2225-2237. PubMed ID: 31008530
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus infection induces indoleamine 2,3-dioxygenase expression in human monocyte-derived macrophages through p38/mitogen-activated protein kinase and NF-κB pathways: impairment in T cell functions.
Liu WL; Lin YH; Xiao H; Xing S; Chen H; Chi PD; Zhang G
J Virol; 2014 Jun; 88(12):6660-71. PubMed ID: 24696473
[TBL] [Abstract][Full Text] [Related]
8. Activation of the noncanonical NF-κB pathway by HIV controls a dendritic cell immunoregulatory phenotype.
Manches O; Fernandez MV; Plumas J; Chaperot L; Bhardwaj N
Proc Natl Acad Sci U S A; 2012 Aug; 109(35):14122-7. PubMed ID: 22879398
[TBL] [Abstract][Full Text] [Related]
9. Activated T cells sustain myeloid-derived suppressor cell-mediated immune suppression.
Pinton L; Solito S; Damuzzo V; Francescato S; Pozzuoli A; Berizzi A; Mocellin S; Rossi CR; Bronte V; Mandruzzato S
Oncotarget; 2016 Jan; 7(2):1168-84. PubMed ID: 26700461
[TBL] [Abstract][Full Text] [Related]
10. Salinomycin promotes T-cell proliferation by inhibiting the expression and enzymatic activity of immunosuppressive indoleamine-2,3-dioxygenase in human breast cancer cells.
Ebokaiwe AP; Njoya EM; Sheng Y; Zhang Z; Li S; Zhou Z; Qiang Z; Peng T; Hussein AA; Zhang G; Lu X; Li L; Wang F
Toxicol Appl Pharmacol; 2020 Oct; 404():115203. PubMed ID: 32822738
[TBL] [Abstract][Full Text] [Related]
11. The role of indoleamine 2,3-dioxygenase-aryl hydrocarbon receptor pathway in the TLR4-induced tolerogenic phenotype in human DCs.
Salazar F; Awuah D; Negm OH; Shakib F; Ghaemmaghami AM
Sci Rep; 2017 Mar; 7():43337. PubMed ID: 28256612
[TBL] [Abstract][Full Text] [Related]
12. Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner.
Holmgaard RB; Zamarin D; Li Y; Gasmi B; Munn DH; Allison JP; Merghoub T; Wolchok JD
Cell Rep; 2015 Oct; 13(2):412-24. PubMed ID: 26411680
[TBL] [Abstract][Full Text] [Related]
13. TLR9-Targeted STAT3 Silencing Abrogates Immunosuppressive Activity of Myeloid-Derived Suppressor Cells from Prostate Cancer Patients.
Hossain DM; Pal SK; Moreira D; Duttagupta P; Zhang Q; Won H; Jones J; D'Apuzzo M; Forman S; Kortylewski M
Clin Cancer Res; 2015 Aug; 21(16):3771-82. PubMed ID: 25967142
[TBL] [Abstract][Full Text] [Related]
14. Classical NF-kappaB activation negatively regulates noncanonical NF-kappaB-dependent CXCL12 expression.
Madge LA; May MJ
J Biol Chem; 2010 Dec; 285(49):38069-77. PubMed ID: 20923761
[TBL] [Abstract][Full Text] [Related]
15. Lymphotoxin-β receptor-NIK signaling induces alternative RELB/NF-κB2 activation to promote metastatic gene expression and cell migration in head and neck cancer.
Das R; Coupar J; Clavijo PE; Saleh A; Cheng TF; Yang X; Chen J; Van Waes C; Chen Z
Mol Carcinog; 2019 Mar; 58(3):411-425. PubMed ID: 30488488
[TBL] [Abstract][Full Text] [Related]
16. Respiratory syncytial virus influences NF-kappaB-dependent gene expression through a novel pathway involving MAP3K14/NIK expression and nuclear complex formation with NF-kappaB2.
Choudhary S; Boldogh S; Garofalo R; Jamaluddin M; Brasier AR
J Virol; 2005 Jul; 79(14):8948-59. PubMed ID: 15994789
[TBL] [Abstract][Full Text] [Related]
17. A mutual activation loop between breast cancer cells and myeloid-derived suppressor cells facilitates spontaneous metastasis through IL-6 trans-signaling in a murine model.
Oh K; Lee OY; Shon SY; Nam O; Ryu PM; Seo MW; Lee DS
Breast Cancer Res; 2013; 15(5):R79. PubMed ID: 24021059
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid receptor signaling contributes to constitutive activation of the noncanonical NF-κB pathway in term human placenta.
Wang B; Palomares K; Parobchak N; Cece J; Rosen M; Nguyen A; Rosen T
Mol Endocrinol; 2013 Feb; 27(2):203-11. PubMed ID: 23239753
[TBL] [Abstract][Full Text] [Related]
19. Suppressive role of myeloid-derived suppressor cells (MDSCs) in the microenvironment of breast cancer and targeted immunotherapies.
Shou D; Wen L; Song Z; Yin J; Sun Q; Gong W
Oncotarget; 2016 Sep; 7(39):64505-64511. PubMed ID: 27542274
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-κB-inducing kinase (NIK) and noncanonical NF-κB signaling.
Cherry EM; Lee DW; Jung JU; Sitcheran R
Mol Cancer; 2015 Jan; 14(1):9. PubMed ID: 25622756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
